The prevalence and health status of people with developmental disabilities in provincial prisons in Ontario, Canada: A retrospective cohort study.

Journal of Applied Research in Intellectual Disabilities : JARID
Lisa WhittinghamFiona G Kouyoumdjian

Abstract

Data on the prevalence of developmental disabilities in people who experience imprisonment and on their characteristics are lacking. The present authors identified adults with developmental disabilities who were released from Ontario provincial prisons in 2010 and a general population comparator group using administrative data. The present authors examined demographic characteristics, morbidity and healthcare use. The prevalence of developmental disabilities was 2.2% in the prison group (N = 52,302) and 0.7% in the general population (N = 10,466,847). The prevalence of psychotic illness, substance-related disorder and self-harm was higher among people in the prison group with developmental disabilities. People with developmental disabilities were more likely to have emergency department visits and hospitalizations in prison and in the year after release. People with developmental disabilities are overrepresented in provincial prisons and have a high burden of disease. Strategies are indicated to prevent incarceration and to improve health.

References

Oct 3, 2002·Public Health Reports·Mary Ann LewisRobert Lindemann
Jul 23, 2003·Research in Developmental Disabilities·Teresa Iacono, Robert Davis
Nov 5, 2003·The Journal of Behavioral Health Services & Research·Haider SaeedPhilip Burge
Jun 24, 2006·International Journal of Law and Psychiatry·Vivienne Catherine RichesRoger James Stancliffe
Jul 7, 2007·Journal of Intellectual & Developmental Disability·Anne G CrockerBernard St-Onge
Jul 20, 2007·International Journal of Offender Therapy and Comparative Criminology·Jessica Jones
Sep 12, 2007·Journal of Intellectual Disability Research : JIDR·H WesterinenM Iivanainen
Jul 23, 2008·International Journal of Law and Psychiatry·Seena FazelJohn Powell
Dec 17, 2009·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Andrea S GershonTeresa To
Aug 17, 2011·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Yasmin KhanMichael J Schull
Oct 18, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Yona LunskyPaul Kurdyak
Oct 31, 2012·Journal of Intellectual Disability Research : JIDR·S DiasN G Lennox
Apr 19, 2013·Criminal Behaviour and Mental Health : CBMH·William R LindsayEleanor Brewster
Aug 9, 2013·Journal of Applied Research in Intellectual Disabilities : JARID·Eric Emerson, Sarah Halpin
Aug 9, 2013·Journal of Applied Research in Intellectual Disabilities : JARID·Matthew Nicoll, Nigel Beail
Nov 17, 2015·Journal of Applied Research in Intellectual Disabilities : JARID·Glynis H MurphyMark J Freeman
Feb 14, 2016·Research in Developmental Disabilities·C F de WinterH M Evenhuis
Jul 31, 2016·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Jessica MoeBrian H Rowe
Oct 22, 2016·BMC Health Services Research·Cynthia KriegIsabelle Dufour
May 4, 2017·Journal of Applied Research in Intellectual Disabilities : JARID·Kirsty DunnSally-Ann Cooper
Sep 13, 2017·Annals of Family Medicine·Jessica A ProkupEmily A Yang
Nov 16, 2017·Psychiatric Services : a Journal of the American Psychiatric Association·Robert BaloghYona Lunsky
Apr 27, 2019·American Journal on Intellectual and Developmental Disabilities·Anna DurbinYona Lunsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.